BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2000
View Archived Issues
Amylin reports phase II results for synthetic exendin-4
Read More
WAY-160910 designated a development candidate, triggering payment to Ligand
Read More
Alfa Wassermann will market and distribute Ligand's oncology products in Italy
Read More
Canstatin is a potent angiogenesis inhibitor in preclinical models
Read More
Cell Therapeutics adds late-stage development compound to pipeline
Read More
Ribonucleotide reductase R2-targeting antisense oligonucleotides for neoplastic diseases
Read More
Hepatotoxicity of HIV protease inhibitors: a real but controllable risk
Read More
NCI begins additional trial of Genta's bcl-2 antisense compound
Read More
OSI Pharmaceuticals licenses gene transcription patent estate to R.W. Johnson
Read More
Strategic alliance formed between Medarex and Kirin Brewery
Read More
Serono and Bioject collaborate on needle-free delivery of hGH
Read More
Positive preclinical results reported for Maxim's oral mucositis gel
Read More
Macrolides synthesized at Pfizer reported to possess broad-spectrum antibacterial activity
Read More
Alpha4-selective integrin antagonists in the Celltech pipeline
Read More
Almirall Prodesfarma presents new PDE5 inhibitor series
Read More
U.S. university researchers design improved trans-platinum complexes
Read More
Agouron's new HIV protease inhibitors show nanomolar antiviral activity, low cytotoxicity
Read More
Novel ADIR compounds active in vitro and in vivo as antitumor agents
Read More
Lipid regulator CI-1027 may also be useful in Alzheimer's disease
Read More
Phase III data reported for rhATIII
Read More
Naturally and non-naturally occurring cyclic depsidecapeptides synthesized and evaluated at Scripps
Read More
Japanese marketing approval no longer sought for Mochida's TNF
Read More
New study indicates potential of kappa-opioid receptor agonists in HIV-1 encephalopathy
Read More
AstraZeneca enters agreement with Vion/EPTTCO for cancer drug delivery technology
Read More
Second pivotal phase III trial of adefovir dipivoxil as HBV treatment initiated
Read More
GnRH-based fusion toxin markedly reduces human colon tumor growth in mouse model
Read More
Milkhaus receives milestone payment from Elan relating to Alzheimer's agreement
Read More